Hodgson Ian 4

4 · Corbus Pharmaceuticals Holdings, Inc. · Filed Feb 4, 2026

AI-generated summary of this filing

Updated Feb 4, 2026

Corbus (CRBP) COO Ian Hodgson Sells 2,415 Shares

What Happened

Ian Hodgson, Chief Operating Officer of Corbus Pharmaceuticals (CRBP), sold 2,415 shares on Feb 3, 2026 at a weighted average price of $8.09 for gross proceeds of approximately $19,537. The sale was a sell-to-cover to satisfy tax withholding obligations related to the vesting and settlement of RSUs, not a discretionary open-market sale.

Key Details

Transaction date: 2026-02-03; Form 4 filed: 2026-02-04.
Price: weighted average $8.09; actual trade prices ranged from $8.01 to $8.15 (multiple trades).
Shares sold: 2,415; proceeds ≈ $19,537.
Purpose: Sell-to-cover for RSU tax withholding (footnote F1); transaction code: S (sale), related to tax withholding.
Holdings note: filing states there are 48,108 unvested RSUs subject to previously disclosed vesting schedules (footnote F3).
The filer offers to provide detailed per-price breakdown on request (footnote F2).
No late filing indicated; transaction reported the next day.

Context

Sell-to-cover transactions are routine when restricted stock units vest and the issuer requires taxes be paid by selling a portion of the shares; such sales are generally administrative and do not necessarily indicate the insider’s view of the company’s prospects.

Form 4

Period: 2026-02-03

Chief Operating Officer

Transactions

Sale
Common Stock, par value $0.0001 per share
[F1][F2][F3]
2026-02-03$8.09/sh−2,415$19,537→ 51,927 total

Footnotes (3)

[F1]The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units ("RSUs"). The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
[F2]The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.01 to $8.15. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F3]This amount includes 48,108 unvested RSUs subject to each grant's vesting schedule as previously reported.

Signature

/s/ Meghan Houghton, attorney-in-fact for Ian Hodgson|2026-02-04

1 file